GROUP ONE TRADING, L.P. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 84 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$304,562
-31.9%
310,778
-3.4%
0.00%0.0%
Q2 2023$447,310
-18.9%
321,806
-7.2%
0.00%
-50.0%
Q1 2023$551,587
-66.1%
346,910
+32.7%
0.00%
-50.0%
Q4 2022$1,628,217
+757.0%
261,351
+1559.0%
0.00%
Q3 2021$190,000
-54.4%
15,754
-20.0%
0.00%
-100.0%
Q2 2021$417,000
+27.5%
19,699
+69.2%
0.00%
Q1 2021$327,000
-41.8%
11,642
-3.6%
0.00%
-100.0%
Q2 2019$562,000
+26.0%
12,078
+8.8%
0.01%0.0%
Q1 2019$446,000
+195.4%
11,100
+237.4%
0.01%
+400.0%
Q4 2018$151,000
-62.9%
3,290
-64.2%
0.00%
-66.7%
Q3 2018$407,000
-72.6%
9,183
-75.8%
0.00%
-76.9%
Q2 2018$1,485,000
+3.6%
37,891
+91.1%
0.01%
-7.1%
Q1 2018$1,434,000
+349.5%
19,828
+309.6%
0.01%
+600.0%
Q4 2017$319,000
-36.2%
4,841
-55.2%
0.00%
-60.0%
Q2 2017$500,000
-75.7%
10,810
-81.5%
0.01%
-79.2%
Q1 2017$2,059,000
+3389.8%
58,312
+1142.8%
0.02%
+2300.0%
Q4 2016$59,000
+391.7%
4,692
+297.0%
0.00%
Q2 2016$12,000
-93.3%
1,182
-88.8%
0.00%
-100.0%
Q1 2016$179,000
-46.7%
10,575
-25.8%
0.00%
-40.0%
Q3 2015$336,000
-83.1%
14,248
-33.7%
0.01%
-83.9%
Q1 2015$1,989,000
+593.0%
21,484
+202.6%
0.03%
+675.0%
Q4 2014$287,0007,1000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2014
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$27,840,84218.82%
Ikarian Capital, LLC 1,891,147$11,781,8462.84%
Altium Capital Management LP 620,000$3,862,6001.96%
Ikarian Capital, LLC 1,296,900$8,079,6871.95%
Parkman Healthcare Partners LLC 822,784$5,125,9441.36%
Deep Track Capital, LP 4,000,000$24,920,0001.05%
Monaco Asset Management SAM 470,100$2,928,7230.88%
BRAIDWELL LP 3,393,405$21,140,9130.71%
Telemetry Investments, L.L.C. 71,000$4420.70%
Rhenman & Partners Asset Management AB 900,000$5,607,0000.58%
View complete list of ESPERION THERAPEUTICS INC NE shareholders